Fiona Costello

Fiona Costello

Auto-generated profile, based on publicly available information

Fiona Costello

Departments of Clinical Neurosciences and Surgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2023 in American Journal of Ophthalmology
Verified
Journal Article
Open access
Raymond P. NajjarRaymond P. Najjar
Raymond P. Najjar
ZTZhiqun Tang
Zhiqun Tang
MLMung Yan Lin
Mung Yan Lin
DWDavid W. Wright
David W. Wright
MKMatthew T. Keadey
Matthew T. Keadey
JKJanvier Ngoy Kilangalanga
Janvier Ngoy Kilangalanga
The Fundus photography vs Ophthalmoscopy Trial Outcomes in the Emergency Department (FOTO-ED) studies showed that ED providers poorly recognized funduscopic findings in patients in the ED. We tested a modified version of the Brain and Optic Nerve Study Artificial Intelligence (BONSAI) deep learning system on nonmydriatic fundus photographs from the FOTO-ED studies to determine if the deep learning system could have improved the detection of papilledema had it been available to ED providers as a real-time diagnostic aid. Retrospective secondary analysis of a cohort of patients included in the FOTO-ED studies. The testing data set included 1608 photographs obtained from 828 patients in the FOTO-ED studies. Photographs were reclassified according to the optic disc classification system used by the deep learning system ("normal optic discs," "papilledema," and "other optic disc abnormalities"). The system's performance was evaluated by calculating the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity using a 1-vs-rest strategy, with reference to expert neuro-ophthalmologists. The BONSAI deep learning system successfully distinguished normal from abnormal optic discs (AUC 0.92 [95% confidence interval {CI} 0.90-0.93]; sensitivity 75.6% [73.7%-77.5%] and specificity 89.6% [86.3%-92.8%]), and papilledema from normal and others (AUC 0.97 [0.95-0.99]; sensitivity 84.0% [75.0%-92.6%] and specificity 98.9% [98.5%-99.4%]). Six patients with missed papilledema in 1 eye were correctly identified by the deep learning system as having papilledema in the other eye. The BONSAI deep learning system was able to reliably identify papilledema and normal optic discs on nonmydriatic photographs obtained in the FOTO-ED studies. Our deep learning system has excellent potential as a diagnostic aid in EDs and non-ophthalmology clinics equipped with nonmydriatic fundus cameras. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

1 December 2018 in Journal of Neuro-Ophthalmology
Verified
Journal Article
Open access
LMLasse Malmqvist
Lasse Malmqvist
LBLulu Bursztyn
Lulu Bursztyn
FCFiona Costello
Fiona Costello
KDKathleen Digre
Kathleen Digre
JFJ. Alexander Fraser
J. Alexander Fraser
Steffen HamannSteffen Hamann
Steffen Hamann

1 May 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
LLLindsey B. De Lott
Lindsey B. De Lott
JBJames F. Burke
James F. Burke
CAChris A. Andrews
Chris A. Andrews
FCFiona Costello
Fiona Costello
WCWayne T. Cornblath
Wayne T. Cornblath
KKKevin A. Kerber
Kevin A. Kerber
The Optic Neuritis Treatment Trial (ONTT) was a landmark randomized clinical trial showing that treatment with corticosteroids does not improve long-term visual outcomes for patients with acute demyelinating typical optic neuritis but may hasten visual recovery in the first 2 weeks.1-3 Given the lack of a robust treatment effect with corticosteroids, the ONTT Study Group and clinical practice guidelines called for shared decision-making between patients and physicians when deciding whether to use corticosteroids for acute neuritis.4 Since the publication of the ONTT findings, the diagnosis of typical optic neuritis remains unchanged, and no additional short-term treatments have emerged. Therefore, the ONTT provides the only actionable data to date for counseling patients on the benefits of corticosteroids.

23 March 2022 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
GLGiulia Longoni
Giulia Longoni
RBRobert A. Brown
Robert A. Brown
AOAde Oyefiade
Ade Oyefiade
RIRenisha Iruthayanathan
Renisha Iruthayanathan
CWColin Wilbur
Colin Wilbur
EYE. Ann Yeh
E. Ann Yeh

1 September 2014 in Journal of Neuro-Ophthalmology
Verified
Journal Article
Closed access
FCFiona E. Costello
Fiona E. Costello
Optical coherence tomography (OCT) has evolved over the past decade to become one of the most important ancillary tests in ophthalmic practice. This noninvasive ocular imaging technique provides high-resolution, cross-sectional images of the retinal nerve fiber layer (RNFL), macular region, ganglion cell layer, and optic nerve head. With OCT, we can learn much about axonal-neuronal integrity in the anterior aspect of the afferent visual pathway and gain insights about mechanisms of brain injury in various central nervous system disorders.

8 October 2021 in Journal of Human Hypertension
Verified
Journal Article
Open access
PDF file
RHRobert J. Herman
Robert J. Herman
AAAnshula Ambasta
Anshula Ambasta
RWR. Geoff Williams
R. Geoff Williams
KZKelly B. Zarnke
Kelly B. Zarnke
FCFiona E. Costello
Fiona E. Costello
THT. Lee-Ann Hawkins
T. Lee-Ann Hawkins
Optical coherence tomography of the eye suggests the retina thins in normal pregnancy. Our objectives were to confirm and extend these observations to women with hypertensive disorders of pregnancy (HDP). Maternal demographics, clinical/laboratory findings and measurements of macular thickness were repeatedly collected at gestational ages <20 weeks, 20-weeks to delivery, at delivery and postpartum. The primary outcome was the change in macular thickness from non-pregnant dimensions in women with incident HDP compared to non-hypertensive pregnant controls. Secondary outcomes were the relationship(s) between mean arterial pressure (MAP) and macular response. Data show macular thicknesses diminished at <20 weeks gestation in each of 27 pregnancies ending in HDP (mean 3.94 µm; 95% CI 4.66, 3.21) and 11 controls (mean 3.92 µm; 5.05, 2.79; P < 0.001 versus non-pregnant dimensions in both; P = 0.983 HDP versus controls). This thinning response continued to delivery in all controls and in 7 women with HDP superimposed on chronic hypertension. Macular thinning was lost after 20 weeks gestation in the other 20 women with HDP. MAP at loss of macular thinning in women without prior hypertension (n = 12) was identical to MAP at enrollment. However, mean MAP subsequently rose 19 mmHg (15, 22) leading to de novo HDP in all 12 women. Loss of thinning leading to a rise in MAP was also observed in 8 of 15 women with HDP superimposed on chronic hypertension. We conclude the macula thins in most women in early pregnancy. Those who lose this early macular thinning response often develop blood pressure elevations leading to HDP.